Diagnosis and Treatment of Diseases of Lipid and Lipoprotein Metabolism in Adults and Children

BACKGROUND
1 Introduction to Lipids and Lipoproteins	Kenneth Feingold, MD and Carl Grunfeld, MD, PhD
2 The Measurement of Lipids, Lipoproteins, Apolipoproteins, Fatty Acids, and Sterols, and Next Generation Sequencing for the Diagnosis and Treatment of Lipid Disorders	Ernst J Schaefer, Fumiyoshi Tsunoda, Margaret Diffenderfer, Eliana Polisecki, Ngoc Thai and Bela Asztalos
3 Utility of Advances Lipoprotein Testing in Clinical Practice	Kenneth Feingold, MD and Carl Grunfeld, MD, PhD
4 The Role of Lipids and Lipoproteins in Atherosclerosis	MacRae F. Linton, MD, Patricia G. Yancey, PhD, Sean S. Davies, PhD, W. Gray (Jay) Jerome, PhD, Edward F. Linton, BA and Kasey C. Vickers, PhD
5 Risk Assessment and Guidelines for the Management of High Blood Cholesterol	Scott Grundy MD
6 Risk of Fasting and Non-Fasting Hypertriglyceridemia in Coronary Vascular Disease and Pancreatitis	Deval Bhatt, M.D. and Lisa Tannock, MD
GENETIC DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM
7 The Severe Hypercholesterolemia Phenotype: Genes and Beyond	Akshay Pendyal, MD and Sergio Fazio MD, PhD
8 Genetic Disorders of Triglyceride Metabolism	Alan Chait, MD, Savitha Subramanian, MD and John D. Brunzell, MD
9 Rare Genetic Disorders Altering Lipoproteins	Michael D. Shapiro, MD
10 Lipodystrophy Syndromes: Presentation and Treatment	Baris Akinci, Melis Sahinoz and Elif Oral
SECONDARY DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM AND SPECIAL POPULATIONS
11 Diabetes and Dyslipidemia	Kenneth Feingold, MD and Carl Grunfeld, MD, PhD
12 Dyslipidemia in Chronic Kidney Disease	Lisa Tannock, MD
13 Lipid and Lipoprotein Metabolism in Liver Disease	Kathleen E. Corey MD, MPH and David E. Cohen MD, PhD
14 The Effect of Endocrine Disorders on Lipids and Lipoproteins	Kenneth Feingold, MD, Eliot A. Brinton, MD, FAHA, FNLA and Carl Grunfeld, MD, PhD
15 The Effect of Inflammation and Infection on Lipids and Lipoproteins	Kenneth Feingold, MD and Carl Grunfeld, MD, PhD
16 Medication Induced Changes in Lipid and Lipoproteins	Megan Herink, Pharm.D., BCPS and Matthew K. Ito, Pharm.D., FCCP, FNLA, CLS.
17 Obesity and Dyslipidemia	Kenneth Feingold, MD and Carl Grunfeld, MD, PhD
18 Management of Dyslipidemia in the Elderly	Dan Streja, MD, FRCPC, FACP, FACE, and Elani Streja, Ph.D.
19 Effect of Pregnancy on Lipid Metabolism and Lipoprotein Levels	Sarah B. Grimes, MD and Robert Wild, MD, MPH, PhD
TREATMENT
20 Approach to the Patient with Dyslipidemia	Kenneth Feingold, MD and Carl Grunfeld, MD, PhD
21 Lifestyle Changes: Effect of Diet, Exercise, Functional Food, and Obesity Treatment, on Lipids and Lipoproteins	Byambaa Enkhmaa, MD, PhD, MAS, Prasanth Surampudi, MD, PhD, Erdembileg Anuurad, MD, PhD, MAS and Lars Berglund, MD, PhD
22 Cholesterol Lowering Drugs	Kenneth Feingold, MD and Carl Grunfeld, MD, PhD
23 Triglyceride Lowering Drugs	Kenneth Feingold, MD and Carl Grunfeld, MD, PhD
24 Lipoprotein Apheresis	Kenneth Feingold, MD and Carl Grunfeld, MD, PhD
PEDIATRIC LIPIDOLOGY
BACKGROUND
25 Is Atherosclerosis a Pediatric Disease	Don P. Wilson, , M.D., FNLA
26 Fetal and Neonatal Cholesterol Metabolism	Laura Woollett and James E Heubi
27 Non-Invasive Imaging in Pediatric Atherosclerosis	Damon B. Dixon, MD
28 Genetics and Dyslipidemia	Nivedita Patni, MD, Zahid Ahmad, MD and Don P. Wilson, , M.D., FNLA
SCREENING AND GUIDELINES
29 Guidelines for Screening, Prevention, Diagnosis, and Treatment of Dyslipidemia in Children and Adolescents	Stephen Daniels
30 Lipid Screening in Youth	Justin Zachariah
HYPERCHOLESTEROLEMIA
31 Familial Hypercholesterolemia	Amy E. Levenson, MD and Sarah D. de Ferranti, MD, MPH
32 Lysosomal Acid Lipase Deficiency	Nirav K. Desai, MD. and Don P. Wilson, , M.D., FNLA
33 Sitosterolemia in the Pediatric Population	Ann Liebeskind, MD and Don P. Wilson, , M.D., FNLA
34 Cerebrotendinous Xanthomatosis	Nivedita Patni, MD and Don P. Wilson, , M.D., FNLA
35 Lipoprotein (a)	Catherine McNeal, MD, PhD.
HYPERTRIGLYCERIDEMIA
36 Genetic Disorders Causing Hypertriglyceridemia in Children and Adolescents	Amy S. Shah, MD MS. and Don P. Wilson, , M.D., FNLA
37 Secondary Hypertriglyceridemia	Piers R Blackett MD, Don P. Wilson, , M.D., FNLA and Catherine McNeal, MD, PhD.
38 Combined Dyslipidemia in Children and Adolescents	Rae-Ellen Kavey
TREATMENT
39 Nutritional Management of Pediatric Dyslipidemia	Lauren A. Williams, MCN, RD and Don P. Wilson, , M.D., FNLA
40 Use of Lipid Lowering Medications in Youth	Melissa L Miller, PharmD and Chanin C Wright, PharmD.